Organto Foods (OGO) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
8 Jun, 2026Market trends and growth drivers
Health and wellness are now global lifestyle standards, with the wellness economy projected to grow 44% to $9.8T by 2029, driving demand for healthy, organic foods.
Organic food markets in Europe and North America are experiencing double-digit CAGRs, with Europe projected at 10.23% and North America at 11.59% through 2029 and 2033, respectively.
Retailers are expanding organic product lines, and public sector demand is increasing, fueling steady volume growth.
Business model and operational strengths
Integrated farm-to-shelf platform controls sourcing, logistics, and delivery, ensuring year-round organic and fairtrade product availability.
Capital-efficient infrastructure enables attractive margins and cash conversion without heavy capital expenditures.
Strong relationships with Europe's largest grocers, with 79% of annual sales from top 7 customers and recurring demand.
Global footprint includes sourcing offices in Latin America and operational hubs in Europe, serving 16 countries and 60 customers.
Financial performance and position
Q1 2026 sales reached a record $25.6M, up 88% year-over-year, with gross profit of $1.8M, up 62%.
Cash operating costs reduced to 6.2% of sales, and positive EBITDA of $0.1M achieved.
Working capital improved to $14.5M, with no long-term debt and positive net equity of $15.7M.
Balance sheet strengthened by expanded funding facility and early warrant exercise, supporting growth.
Latest events from Organto Foods
- Record sales and gross profit in 2023, but net loss widened amid restructuring and higher charges.OGO
Q4 20238 Jun 2026 - Q1 2024 saw improved net loss and cost cuts amid restructuring and 11% lower sales.OGO
Q1 20248 Jun 2026 - Q2 2024 delivered higher sales, net income, and lower overhead following restructuring and asset sales.OGO
Q2 20248 Jun 2026 - Q3 2024 delivered 47% sales growth and a sharply reduced net loss after restructuring.OGO
Q3 20248 Jun 2026 - Record Q4 sales and margin growth highlight strong momentum after restructuring.OGO
Q4 20248 Jun 2026 - Record sales, first positive EBITDA, and improved margins signal strong turnaround momentum.OGO
Q1 20258 Jun 2026 - Record sales and margin gains offset by non-recurring restructuring and debt settlement costs.OGO
Q2 20258 Jun 2026 - Record quarterly sales and gross profit, with strengthened balance sheet and reduced debt.OGO
Q3 20258 Jun 2026 - Record sales and EBITDA, strong balance sheet, and annualized sales surpass EUR 100 million.OGO
Q1 202628 May 2026